SCHEMBL6170307

SCHEMBL6170307

CCOC(=O)c1ccc([N+](=O)[O-])c(N(C=O)C2(Cc3ccccc3Cl)CCC2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.42
MEN1 O00255 2/20 0.42
MAPT P10636 4/20 0.42
ALDH1A1 P00352 8/20 0.38
RAB9A P51151 2/20 0.38
NPC1 O15118 1/20 0.38
PKM P14618 1/20 0.38
CRHBP P24387 1/20 0.38
CRHR2 Q13324 1/20 0.38
GAA P10253 3/20 0.38
KDM4E B2RXH2 2/20 0.38
LMNA P02545 2/20 0.38
POLB P06746 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
ALOX12 P18054 1/20 0.37
PTGER4 P35408 1/20 0.36
HTT P42858 2/20 0.36
THRB P10828 1/20 0.35
PDE3B Q13370 1/20 0.35
PDE3A Q14432 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6170305 0.78 KMT2A (0.46) KMT2AMEN1MAPTALDH1A1RAB9A
SCHEMBL6170301 0.76 MAPT (0.47) KMT2AMEN1MAPTALDH1A1RAB9A
SCHEMBL6170389 0.76 KMT2A (0.48) KMT2AMEN1MAPTALDH1A1RAB9A
SCHEMBL6167784 0.74 KMT2A (0.47) KMT2AMEN1MAPTALDH1A1RAB9A
SCHEMBL6169759 0.71 KMT2A (0.43) KMT2AMEN1MAPTALDH1A1RAB9A
SCHEMBL6169083 0.70 MAPT (0.49) KMT2AMEN1MAPTALDH1A1RAB9A
SCHEMBL6170740 0.69 KMT2A (0.46) KMT2AMEN1MAPTALDH1A1RAB9A
SCHEMBL13497805 0.69 KMT2A (0.61) KMT2AMEN1MAPTALDH1A1RAB9A
SCHEMBL6170369 0.69 KMT2A (0.47) KMT2AMEN1MAPTALDH1A1RAB9A
SCHEMBL6170395 0.68 KMT2A (0.48) KMT2AMEN1MAPTALDH1A1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0882718-B1 BENZIMIDAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO (JP) 2005-08-31 EP disclosed
US-6352985-B1 CARDIOVASCULAR DISORDERS OR GASTROINTESTINAL DISORDERS, DIABETES (TYPE II DIABETES), DIABETIC COMPLICATIONS METHOD FOR LOWERING THE BLOOD SUGAR LEVEL OF A PATIENT, FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-03-05 US disclosed
US-6166219-A Benzimidazole derivatives FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-12-26 US disclosed
EP-0882718-A1 BENZIMIDAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-12-09 EP disclosed